Ligand validation:8TVM

VDC: N-{1-[(1R,2R)-2-fluorocyclopropyl]-2-oxo-1,2-dihydropyridin-3-yl}-2-[(1R,4r)-1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl]-6-[(propan-2-yl)oxy]-2H-pyrazolo[3,4-b]pyridine-5-carboxamide

VDC is a Ligand Of Interest in 8TVM designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8TVM_VDC_D_501	78%	19%	0.113	0.957	0.98	2.44	2	13	0	0	100%	1
8TVM_VDC_C_501	76%	18%	0.117	0.954	0.98	2.48	2	11	0	0	100%	1
8TVM_VDC_B_501	66%	24%	0.144	0.948	0.99	2.11	2	10	0	0	100%	1
8TVM_VDC_A_501	56%	24%	0.163	0.935	0.98	2.11	2	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.